Stay updated on Lifileucel + Pembrolizumab vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Lifileucel + Pembrolizumab vs Pembrolizumab Clinical Trial page.

Latest updates to the Lifileucel + Pembrolizumab vs Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedFooter updates include a new site Revision: v3.3.3 and the removal of the HHS Vulnerability Disclosure link, along with the prior Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the site-wide government funding and operating status notice from the page; the study record content and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange DetectedA new version entry was added to the record history, reflecting updated study status and contacts/locations. This is part of ongoing record maintenance and does not modify the underlying study details.SummaryDifference0.1%

- Check82 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference10%

- Check89 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Lifileucel + Pembrolizumab vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lifileucel + Pembrolizumab vs Pembrolizumab Clinical Trial page.